Natixis’s Kindred Healthcare KND Stock Holding History

Natixis’s Portfolio KND Stock Details KND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-13,201	Closed	-$90K	–	1351
2017 Q3	$90K	Buy	+13,201	New	+$112K	﹤0.01%	1192
2013 Q3	–	Sell	-19,900	Closed	-$261K	–	587
2013 Q2	$261K	Buy	+19,900	New	+$238K	﹤0.01%	379

Other funds holding KND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BCM

Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Natixis's KND Position: Q4 2017 in Review

Natixis sold out of Kindred Healthcare (KND) in Q4 2017, closing a stake of 13,201 shares — an estimated $90K sold.

Natixis first reported a position in KND in Q2 2013 and held it in 2 quarters. The position peaked at $261K in Q2 2013. 181 funds tracked by Wall St. Rank hold KND as of Q4 2017.

Natixis reported no remaining Kindred Healthcare position as of Q4 2017 after selling out during the quarter.
Natixis sold 13,201 Kindred Healthcare shares in Q4 2017, an estimated $90K.
Natixis first reported a position in Kindred Healthcare in Q2 2013 and held it in 2 quarters.
Natixis's Kindred Healthcare position peaked at $261K in Q2 2013.
181 funds tracked by Wall St. Rank held Kindred Healthcare as of Q4 2017.

Based on Natixis's 13F filing for Q4 2017, filed 14 Feb 2018.